233 related articles for article (PubMed ID: 35145256)
1. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats.
Arandel L; Matloka M; Klein AF; Rau F; Sureau A; Ney M; Cordier A; Kondili M; Polay-Espinoza M; Naouar N; Ferry A; Lemaitre M; Begard S; Colin M; Lamarre C; Tran H; Buée L; Marie J; Sergeant N; Furling D
Nat Biomed Eng; 2022 Feb; 6(2):207-220. PubMed ID: 35145256
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
3. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
5. FISH Protocol for Myotonic Dystrophy Type 1 Cells.
Klein AF; Arandel L; Marie J; Furling D
Methods Mol Biol; 2020; 2056():203-215. PubMed ID: 31586350
[TBL] [Abstract][Full Text] [Related]
6. Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.
Paul S; Dansithong W; Jog SP; Holt I; Mittal S; Brook JD; Morris GE; Comai L; Reddy S
J Biol Chem; 2011 Nov; 286(44):38427-38438. PubMed ID: 21900255
[TBL] [Abstract][Full Text] [Related]
7. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
8. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
9. Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice.
Klein AF; Varela MA; Arandel L; Holland A; Naouar N; Arzumanov A; Seoane D; Revillod L; Bassez G; Ferry A; Jauvin D; Gourdon G; Puymirat J; Gait MJ; Furling D; Wood MJ
J Clin Invest; 2019 Nov; 129(11):4739-4744. PubMed ID: 31479430
[TBL] [Abstract][Full Text] [Related]
10. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
[TBL] [Abstract][Full Text] [Related]
11. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
Sobczak K; Wheeler TM; Wang W; Thornton CA
Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
[TBL] [Abstract][Full Text] [Related]
12. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
13. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
14. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
[TBL] [Abstract][Full Text] [Related]
15. hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies.
Alexander MS; Hightower RM; Reid AL; Bennett AH; Iyer L; Slonim DK; Saha M; Kawahara G; Kunkel LM; Kopin AS; Gupta VA; Kang PB; Draper I
Muscle Nerve; 2021 Jun; 63(6):928-940. PubMed ID: 33651408
[TBL] [Abstract][Full Text] [Related]
16. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.
Wong CH; Nguyen L; Peh J; Luu LM; Sanchez JS; Richardson SL; Tuccinardi T; Tsoi H; Chan WY; Chan HY; Baranger AM; Hergenrother PJ; Zimmerman SC
J Am Chem Soc; 2014 Apr; 136(17):6355-61. PubMed ID: 24702247
[TBL] [Abstract][Full Text] [Related]
17. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.
Wheeler TM; Sobczak K; Lueck JD; Osborne RJ; Lin X; Dirksen RT; Thornton CA
Science; 2009 Jul; 325(5938):336-9. PubMed ID: 19608921
[TBL] [Abstract][Full Text] [Related]
18. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
19. Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1.
Wheeler TM; Krym MC; Thornton CA
Neuromuscul Disord; 2007 Mar; 17(3):242-7. PubMed ID: 17306536
[TBL] [Abstract][Full Text] [Related]
20. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
